Ribonucleotide reductase M2 subunit is a novel diagnostic marker and a potential therapeutic target in bladder cancer (original) (raw)
Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: longitudinal expression, transcriptome-level effects and modulation of chemosensitivity
bruce moran
BMC Cancer
View PDFchevron_right
The ribonucleotide reductase large subunit (RRM1) as a predictive factor in patients with cancer
Pascal Sève
The Lancet Oncology, 2011
View PDFchevron_right
RNA-binding proteins RBM-HuR, RBM3 and PODXL expression in urothelial carcinoma of the urinary bladder. Prognostic and clinical implications
Shereen Elshorbagy
Contemporary Oncology, 2021
View PDFchevron_right
Expression of ribonucleoside reductase subunit M1, but not excision repair cross-complementation group 1, is predictive in muscle-invasive bladder cancer treated with chemotherapy and radiation
Daniel Hamstra
Molecular and clinical oncology, 2014
View PDFchevron_right
The effect of RORα expression on the development of biological malignancy of urinary bladder cancer
Anna Brożyna
Medical Research Journal
View PDFchevron_right
Gene Section Atlas of Genetics and Cytogenetics in Oncology and Haematology INIST-CNRS OPEN ACCESS JOURNAL RRM2 (ribonucleotide reductase M2)
Hamid Fiuji
View PDFchevron_right
Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer
Göran Ahlgren
BMC Urology, 2013
View PDFchevron_right
Knockdown of RRM1 with Adenoviral shRNA Vectors to Inhibit Tumor Cell Viability and Increase Chemotherapeutic Sensitivity to Gemcitabine in Bladder Cancer Cells
Rikiya Taoka
International Journal of Molecular Sciences, 2021
View PDFchevron_right
Elevated and Absent PRb Expression is Associated With Bladder Cancer Progression and Has Cooperative Effects With P53
Richard Cote
Cancer research, 1998
View PDFchevron_right
Retinoblastoma protein expression and radiation response in muscle-invasive bladder cancer
William Benedict
International Journal of Radiation Oncology*Biology*Physics, 1997
View PDFchevron_right
Implication of RAF and RKIP genes in urinary bladder cancer
Demetrios Spandidos
Pathology oncology research : POR, 2011
View PDFchevron_right
The prognostic value of MDM2 overexpression in superficial urothelial bladder carcinoma
Sofia Pereira
Clinical & Translational Oncology, 2002
View PDFchevron_right
Post-transcriptional regulation of MRE11 expression in muscle-invasive bladder tumours
Selina Bhattarai
Oncotarget, 2014
View PDFchevron_right
Molecular Aspects of Bladder Cancer
Jose Carlos Vieira
European Urology, 2002
View PDFchevron_right
Report From the International Society of Urological Pathology (ISUP) Consultation Conference On Molecular Pathology Of Urogenital Cancers. II. Molecular Pathology of Bladder Cancer
Sofía Portillo
American Journal of Surgical Pathology, 2020
View PDFchevron_right
A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors
wang bin
PeerJ
View PDFchevron_right
Expression of RFC/SLC19A1 is Associated with Tumor Type in Bladder Cancer Patients
Mona Rady
PLoS ONE, 2011
View PDFchevron_right
Therapy-relevant aberrant expression of MRP3 and BCRP mRNA in TCC-/SCC-bladder cancer tissue of untreated patients
Mona Rady
Oncology Reports, 2017
View PDFchevron_right
Tumour expression of bladder cancer-associated urinary proteins
Christer Busch
BJU International, 2013
View PDFchevron_right
Biomarkers in bladder cancer: Translational and clinical implications
Antonio Lopez-beltran
Critical Reviews in Oncology/Hematology, 2014
View PDFchevron_right
Expression profile of Rho kinases in urinary bladder cancer
Vassilis Zoumpourlis
Journal of B.U.ON. : official journal of the Balkan Union of Oncology
View PDFchevron_right
Expression of ribonucleotide reductase M2 subunit in gastric cancer and effects of RRM2 inhibition in vitro
Aya Shinozaki-Ushiku
Human pathology, 2010
View PDFchevron_right
The interrelationships between Src, Cav-1 and RhoGD12 in transitional cell carcinoma of the bladder
Александр Франк
British journal of cancer, 2012
View PDFchevron_right
Biomarkers for detection, treatment decision and prognosis of the urinary bladder cancer
Zana Dolicanin
View PDFchevron_right
Molecular Alterations Associated With Bladder Cancer Progression
Marta Sanchez-carbayo
Seminars in Oncology, 2007
View PDFchevron_right
Molecular alterations associated with bladder cancer initiation and progression
Marta Sanchez-carbayo
Scandinavian Journal of Urology and Nephrology, 2008
View PDFchevron_right
The src-family kinase inhibitor PP2 suppresses the in vitro invasive phenotype of bladder carcinoma cells via modulation of Akt
John Stoffel
BJU International, 2005
View PDFchevron_right
Coexpression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder
Pei-Yin Hsu
British Journal of Cancer, 2005
View PDFchevron_right